Please assess the completion status of the following clinical trial:

Trial Title: The Avelle® Negative Pressure Wound Therapy System on Chronic Wounds

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Venous insufficiency as defined by CEAP Classification of C6 or C6R or Diabetic foot ulcer~* Stalled wound/failed treatment in the opinion of the investigator. Defined as a wound that has not progressed by more than 30% in the previous 4 weeks~* 1 qualifying wound which is amenable to NPWT~* Reliable and available for follow-up~* Low to moderate exudate~* Able to tolerate negative pressure~* \>18 years old at the time of consent~* Able and willing to provide informed consent~Exclusion Criteria:~* Known sensitivities or allergies to components of the Avelle™ Negative Pressure Wound Therapy System~* Necrotic wounds or wounds with eschar present~* Wound is too small or too large based on wound dressing (\> 1cm2 and \< 100cm2)~* Wound depth \>2cm~* Use of DuoDERM® gel /petroleum gel/ creams/oil-based products~* Active treatment for cancer or completed within the last 3 months~* Severe malnutrition in the opinion of the investigator~* Visible bone/tendon or exposed articular capsule~* Exposed blood vessels~* Clotting disorder~* Malignant wounds~* Systemic infection~* Untreated osteomyelitis~* Patients with HbA1c greater than 9 on Day 0 (Test to be performed within last 3 months)~* Wounds greater than 12 months old~* Previous failed NPWT within last 6 weeks on the qualifying wound~* Active Pregnancy~* Chronic Kidney Disease score of 5

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Avelle NPWT (Type: None): Avelle Negative Pressure Wound Therapy administered as indicated by the IFU.

Based on this trial design, predict the completion outcome and termination type (if applicable).